Making new medicines available for patients is a complex process taking many years, in which our company investigates thousands of potential new medicines for every one that proves to be safe, effective, and can be prescribed by doctors.
Welcome to Mitsubishi Tanabe Pharma Europe Ltd
Mitsubishi Tanabe Pharma Europe acts as the European Headquarters of one of Japan’s leading pharmaceutical companies, Mitsubishi Tanabe Pharma Corporation. Based in London, we are dedicated to the clinical development of new medicines for the European markets. We are the marketing authorisation holder for Exembol®, Argatra®, Arganova® and Novastan® (argatroban) and support commercial operations for other in-house products.
Clinical Research
Disease Areas
Our headquarters, Mitsubishi Tanabe Pharma Corporation, based in Japan, is involved in many research projects into many different diseases, some of which involve Mitsubishi Tanabe Pharma Europe.
Work For Us
This is simply a great place to work. We care about the careers and lives of our employees, which is rare in subsidiaries of large global corporations. This makes us special.
Our Products
This section contains specific information on our products in individual countries.